A study on changes in lung function, neutralizing antibodies, and symptoms of adult patients hospitalized with COVID-19

다국어 초록 (Multilingual Abstract)

Background/Aims: To identify changes in symptoms and pulmonary sequelae in patients with coronavirus disease 2019 (COVID-19).
Methods: Patients with COVID-19 hospitalized at seven university hospitals in Korea between February 2020 and February 2021 were enrolled, provided they had ≥ 1 outpatient follow-up visit. Between January 11 and March 9, 2021 (study period), residual symptom investigations, chest computed tomography (CT) scans, pulmonary function tests (PFT), and neutralizing antibody tests (NAb) were performed at the outpatient visit (cross-sectional design). Additionally, data from patients who already had follow-up outpatient visits before the study period were collected retrospectively.
Results: Investigation of residual symptoms, chest CT scans, PFT, and NAb were performed in 84, 35, 31, and 27 patients, respectively. After 6 months, chest discomfort and dyspnea persisted in 26.7% (4/15) and 33.3% (5/15) patients, respectively, and 40.0% (6/15) and 26.7% (4/15) patients experienced financial loss and emotional distress, respectively. When the ratio of later CT score to previous ones was calculated for each patient between three different time intervals (1–14, 15–60, and 61–365 days), the median values were 0.65 (the second interval to the first), 0.39 (the third to the second), and 0.20 (the third to the first), indicating that CT score decreases with time. In the high-severity group, the ratio was lower than in the low-severity group.
Conclusions: In COVID-19 survivors, chest CT score recovers over time, but recovery is slower in severely ill patients. Subjects complained of various ongoing symptoms and socioeconomic problems for several months after recovery.

참고문헌 (Reference)

• 1 World Health Organization, "Weekly operational update on COVID-19: 12 October 2021" WHO
• 2 Pan F, "Time course of lung changes at chest CT during recovery from coronavirus disease 2019(COVID-19)" 295 : 715-721, 2020
• 3 Funke-Chambour M, "Swiss recommendations for the follow-up and treatment of pulmonary long COVID" 100 : 826-841, 2021
• 4 Graham BL, "Standardization of spirometry 2019 update : an official American Thoracic Society and European Respiratory Society technical statement" 200 : e70-e88, 2019
• 5 Faverio P, "Six-month pulmonary impairment after severe COVID-19 : a prospective, multicentre follow-up study" 100 : 1078-1087, 2021
• 6 Bellan M, "Respiratory and psychophysical sequelae among patients with COVID-19four months after hospital discharge" 4 : e2036142-, 2021
• 7 Donnelly JP, "Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system" 325 : 304-306, 2021
• 8 Eksombatchai D, "Pulmonary function and six-minute-walk test in patients after recovery from COVID-19 : a prospective cohort study" 16 : e0257040-, 2021
• 9 Weerahandi H, "Post-discharge health status and symptoms in patients with severe COVID-19" 36 : 738-745, 2021
• 10 Caruso D, "Post-acute sequelae of COVID-19 pneumonia : six-month chest CT follow-up" 301 : E396-E405, 2021
• 11 Nalbandian A, "Post-acute COVID-19syndrome" 27 : 601-615, 2021
• 12 Augustin M, "Post-COVID syndrome in non-hospitalised patients with COVID-19 : a longitudinal prospective cohort study" 6 : 100122-, 2021
• 13 Ayoubkhani D, "Post-COVID syndrome in individuals admitted to hospital with covid-19 : retrospective cohort study" 372 : n693-, 2021
• 14 Townsend L, "Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity" 18 : 997-1003, 2021
• 15 Chen Y, "One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection" 19 : 191-, 2021
• 16 Lopez-Leon S, "More than 50 long-term effects of COVID-19 : a systematic review and meta-analysis" 11 : 16144-, 2021
• 17 Piccoli L, "Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology" 183 : 1024-1042, 2020
• 18 Vanshylla K, "Kinetics and correlates of the neutralizing antibody response to SARSCoV-2 infection in humans" 29 : 917-929, 2021
• 19 Froidure A, "Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae" 181 : 106383-, 2021
• 20 Taquet M, "Incidence, co-occurrence, and evolution of long-COVID features : a 6-month retrospective cohort study of 273, 618survivors of COVID-19" 18 : e1003773-, 2021
• 21 Huang Y, "Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase" 21 : 163-, 2020
• 22 Dan JM, "Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection" 371 : eabf4063-, 2021
• 23 van Gassel RJ, "High prevalence of pulmonary sequelae at 3 months after hospital discharge in mechanically ventilated survivors of COVID-19" 203 : 371-374, 2021
• 24 McDonald LT, "Healing after COVID-19: are survivors at risk for pulmonary fibrosis?" 320 : L257-L265, 2021
• 25 Zhao Y, "Follow-up study on COVID-19survivors one year after discharge from hospital" 112 : 173-182, 2021
• 26 Zhao YM, "Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery" 25 : 100463-, 2020
• 27 Zhang S, "Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors" 11 : 13854-, 2021
• 28 Pan F, "Chest CT patterns from diagnosis to 1 year of follow-up in patients with COVID-19" 302 : 709-719, 2022
• 29 Tabatabaei SM, "Chest CT in COVID-19 pneumonia : what are the findings in mid-term follow-up?" 27 : 711-719, 2020
• 30 National Institute for Health and Care Excellence, "COVID-19rapid guideline: managing the long-term effects of COVID-19" NICE
• 31 Garcia-Beltran WF, "COVID-19-neutralizing antibodies predict disease severity and survival" 184 : 476-488, 2021
• 32 Menges D, "Burden of post-COVID-19 syndrome and implications for healthcare service planning : a population-based cohort study" 16 : e0254523-, 2021
• 33 Ren L, "Antibody responses and clinical outcomes in adults hospitalized with severe coronavirus disease 2019(COVID-19) : a post hoc analysis of LOTUS China Trial" 72 : e545-e551, 2021
• 34 Orzes N, "A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia" 186 : 106541-, 2021
• 35 WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection, "A minimal common outcome measure set for COVID-19 clinical research" 20 : e192-e197, 2020
• 36 Wu Q, "A follow-up study of lung function and chest computed tomography at 6 months after discharge in patients with coronavirus disease 2019" 2021 : 6692409-, 2021
• 37 Huang C, "6-Month consequences of COVID-19 in patients discharged from hospital : a cohort study" 397 : 220-232, 2021